GI Innovation Company
GI Innovation is a global leader of microbiome drug development.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date:
2017
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership